Robert V. Moquin

1.4k citations

20 papers · 630 · h-index 16

Impact in

Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Toxicology top 10%

Papers in

Organic Chemistry 11
- Chemical synthesis and alkaloids 4
- Synthesis and biological activity 3
- Synthesis and Biological Evaluation 3
- Quinazolinone synthesis and applications 2
Molecular Biology 10
- Melanoma and MAPK Pathways 6
- Phenothiazines and Benzothiazines Synthesis and Activities 3

Co-authors: Jagabandhu Das (11 shared papers)Joel C. Barrish (10 shared papers)James C. Lin (7 shared papers)Arthur M. Doweyko (6 shared papers)John Wityak (6 shared papers)David Floyd (5 shared papers)Gary L. Schieven (6 shared papers)Ding Ren Shen (6 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)Tetrahedron Letters (1 paper)Xenobiotica (1 paper)
Partner nations: United States Germany Japan

In The Last Decade

Robert V. Moquin

20 papers receiving 601 citations

Peers

Countries citing papers authored by Robert V. Moquin

Since Specialization

Citations

This map shows the geographic impact of Robert V. Moquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. Moquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. Moquin more than expected).

Fields of papers citing papers by Robert V. Moquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert V. Moquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. Moquin. The network helps show where Robert V. Moquin may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert V. Moquin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert V. Moquin Line = papers co-authored together Robert V. Moquin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Robert V. Moquin, James C. Lin, Chunjian Liu, Arthur M. Doweyko, Henry F. DeFex, Qiong Fang, Suhong Pang, Sidney Pitt, Ding Ren Shen, Gary L. Schieven, Joel C. Barrish, John Wityak	2003	94
2	Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Joseph A. Furch, Chunjian Liu, Robert V. Moquin, James C. Lin, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Chen-Yi Hung, Arthur M. Doweyko, Amrita V. Kamath, Hongjian Zhang, Punit Marathe, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	66
3	Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones Journal of Medicinal Chemistry ·David Floyd, S. David Kimball, John Krapcho, (unknown), Chester F. Turk, Robert V. Moquin, Michael W. Lago, Keith J. Duff, Ving G. Lee	1992	61
4	Molecular design, synthesis, and structure–Activity relationships leading to the potent and selective p56lck inhibitor BMS-243117 Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, James C. Lin, Robert V. Moquin, Zhongqi Shen, Steven H. Spergel, John Wityak, Arthur M. Doweyko, Henry F. DeFex, Qiong Fang, Suhong Pang, Sidney Pitt, Ding Ren Shen, Gary L. Schieven, Joel C. Barrish	2003	51
5	Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck Bioorganic & Medicinal Chemistry Letters ·John Wityak, Jagabandhu Das, Robert V. Moquin, Zhongqi Shen, James C. Lin, Ping Chen, Arthur M. Doweyko, Sidney Pitt, Suhong Pang, Ding Ren Shen, Qiong Fang, H. Fex, Gary L. Schieven, Steven B. Kanner, Joel C. Barrish	2003	47
6	Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site Journal of Medicinal Chemistry ·S. David Kimball, David Floyd, (unknown), John T. Hunt, John Krapcho, George C. Rovnyak, Keith J. Duff, Ving G. Lee, Robert V. Moquin	1992	40
7	Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Robert V. Moquin, Sidney Pitt, Rosemary Zhang, Ding Ren Shen, Kim W. McIntyre, Kathleen M. Gillooly, Arthur M. Doweyko, John S. Sack, Hongjian Zhang, Susan E. Kiefer, Kevin Kish, Murray McKinnon, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2008	38
8	Synthesis of benzazepinone and 3-methylbenzothiazepinone analogs of diltiazem The Journal of Organic Chemistry ·David Floyd, Robert V. Moquin, Karnail S. Atwal, Sayed Z. Ahmed, Steven H. Spergel, Jack Z. Gougoutas, Mary F. Malley	1990	36
9	Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Chunjian Liu, Robert V. Moquin, James C. Lin, Joseph A. Furch, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Chen-Yi Hung, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	31
10	Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones Journal of Medicinal Chemistry ·(unknown), David Floyd, S. David Kimball, Keith J. Duff, Michael W. Lago, Robert V. Moquin, Ving G. Lee, Jack Z. Gougoutas, Vu Chi Truc	1992	22
11	5-Amino-pyrazoles as potent and selective p38α inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Robert V. Moquin, Alaric J. Dyckman, Tianle Li, Sidney Pitt, Rosemary Zhang, Ding Ren Shen, Kim W. McIntyre, Kathleen M. Gillooly, Arthur M. Doweyko, John A. Newitt, John S. Sack, Hongjian Zhang, Susan E. Kiefer, Kevin Kish, Murray McKinnon, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2010	20
12	Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA Bioorganic & Medicinal Chemistry Letters ·Soong‐Hoon Kim, John S. Tokarski, Kenneth J. Leavitt, Brian E. Fink, Mark Salvati, Robert V. Moquin, Mary T. Obermeier, George L. Trainor, Gregory G. Vite, Linda K. Stadnick, Jonathan Lippy, Dan You, Matthew V. Lorenzi, Ping Chen	2007	20
13	Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase Bioorganic & Medicinal Chemistry Letters ·James Kempson, Junqing Guo, Jagabandhu Das, Robert V. Moquin, Steven H. Spergel, Scott H. Watterson, Charles M. Langevine, Alaric J. Dyckman, Mark A. Pattoli, James R. Burke, Xiao-Xia Yang, Kathleen M. Gillooly, Kim W. McIntyre, Laishun Chen, John H. Dodd, Murray McKinnon, Joel C. Barrish, William J. Pitts	2009	17
14	Synthesis of imidazo[1,5-a]quinoxalin-4(5H)-one template via a novel intramolecular cyclization process Tetrahedron Letters ·Derek Norris, Ping Chen, Joel C. Barrish, Jagabandhu Das, Robert V. Moquin, Bang‐Chi Chen, Peng Guo	2001	17
15	Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency Bioorganic & Medicinal Chemistry Letters ·Ping Chen, Edwin J. Iwanowicz, Derek Norris, Henry H. Gu, James C. Lin, Robert V. Moquin, Jagabandhu Das, John Wityak, Steven H. Spergel, Henry de Fex, Suhong Pang, Sydney Pitt, Ding Ren Shen, Gary L. Schieven, Joel C. Barrish	2002	16
16	Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Harold N. Weller, Arthur V. Miller, Robert V. Moquin, Kenneth E.J. Dickinson, S.Anders Hedberg, Suzanne Moreland, Robert Cohen, Carol L. Delaney, Stephen Skwish, Sharon B. Williams	1992	15
17	Synthesis and photochemistry of heterocyclic norbornenyl ketones The Journal of Organic Chemistry ·Ronald R. Sauers, Annette Hagedorn, Susan D. Van Arnum, Robert Gomez, Robert V. Moquin	1987	14
18	Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole Xenobiotica ·W. Griffith Humphreys, Mary T. Obermeier, Samuel S. Chong, S. David Kimball, J. Das, Pengyi Chen, Robert V. Moquin, Weichao Han, Richard Gedamke, Roseann White, Richard A. Morrison	2003	11
19	Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, S. David Kimball, Steven E. Hall, Wen-Ching Han, Edwin J. Iwanowicz, James C. Lin, Robert V. Moquin, Joyce A. Reid, John S. Sack, Mary F. Malley, ChiehYing Y. Chang, Saeho Chong, David Wang‐Iverson, Daniel G. Roberts, Steven M. Seiler, William A. Schumacher, Martin L. Ogletree	2002	10
20	ChemInform Abstract: Synthesis of Benzazepinone and 3‐Methylbenzothiazepinone Analogues of Diltiazem. ChemInform ·David Floyd, Robert V. Moquin, K. S. ATWAL, Sayed Z. Ahmed, Steven H. Spergel, Jack Z. Gougoutas, Mary F. Malley	1991	4

About Robert V. Moquin

Robert V. Moquin is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Cancer Research and Computational Theory and Mathematics, having authored 20 papers that have together received 630 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Chemical synthesis and alkaloids (4 papers), Synthesis and biological activity (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), NF-κB Signaling Pathways (3 papers), Synthesis and Biological Evaluation (3 papers), Quinazolinone synthesis and applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Organic Chemistry (398 citations), Toxicology (18 citations), Oncology (95 citations), Molecular Biology (241 citations) and Computational Theory and Mathematics (53 citations). Robert V. Moquin has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Jagabandhu Das, Joel C. Barrish, James C. Lin, Arthur M. Doweyko, John Wityak, David Floyd, Gary L. Schieven, Ding Ren Shen, Steven H. Spergel and Sidney Pitt. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Tetrahedron Letters and Xenobiotica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Robert V. Moquin

Impact in

Papers in i

In The Last Decade

Robert V. Moquin

Peers

Countries citing papers authored by Robert V. Moquin

Fields of papers citing papers by Robert V. Moquin

All Works

About Robert V. Moquin

Explore authors with similar magnitude of impact

Papers in